Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
23 January 2020 | Story Lacea Loader

Update: 26 January 2020
Bloemfontein Campus registration process to continue on Monday 27 January 2020

The registration process for students on the Bloemfontein Campus of the University of the Free State (UFS) will continue on Monday 27 January 2020 as per the registration programme.

First-year students who have not registered must refer to their email, the university’s self-service portal, and the Call Centre (051 401 9666) for information. Senior students can visit registration venues on campus if they require academic advice.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



Update: 24 January 2020
Bloemfontein Campus registration process not to continue the afternoon of Friday 24 January 2020  

The first-year registration process on the Bloemfontein Campus will not continue after 13:00 today (Friday 24 January 2020), but will resume on Monday 27 January 2020.

This decision taken by the executive management of the university comes after a number of students disrupted the registration process this morning and prevented first-year students to enter registration venues.

Constant engagements with the Institutional Student Representative Council (ISRC) and the Student Representative Council (SRC) of the Bloemfontein Campus have taken place since the beginning of the year regarding matters of concern to students, and the executive management will continue to do so. The university management is disappointed with this morning’s disruptive behaviour led by the Bloemfontein Campus SRC, despite these regular engagements.

The situation on the campus is being closely monitored by the university’s Protection Services and the South African Police Service.

 

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept